IBDEI0O8 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11081,0)
 ;;=J11.1^^68^677^44
 ;;^UTILITY(U,$J,358.3,11081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11081,1,3,0)
 ;;=3^Influenza d/t Unident Influenza Virus w/ Oth Resp Manifest
 ;;^UTILITY(U,$J,358.3,11081,1,4,0)
 ;;=4^J11.1
 ;;^UTILITY(U,$J,358.3,11081,2)
 ;;=^5008158
 ;;^UTILITY(U,$J,358.3,11082,0)
 ;;=N12.^^68^677^85
 ;;^UTILITY(U,$J,358.3,11082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11082,1,3,0)
 ;;=3^Tubulo-Interstitial Nephritis
 ;;^UTILITY(U,$J,358.3,11082,1,4,0)
 ;;=4^N12.
 ;;^UTILITY(U,$J,358.3,11082,2)
 ;;=^5015575
 ;;^UTILITY(U,$J,358.3,11083,0)
 ;;=N11.9^^68^677^86
 ;;^UTILITY(U,$J,358.3,11083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11083,1,3,0)
 ;;=3^Tubulo-Interstitial Nephritis,Chronic
 ;;^UTILITY(U,$J,358.3,11083,1,4,0)
 ;;=4^N11.9
 ;;^UTILITY(U,$J,358.3,11083,2)
 ;;=^5015574
 ;;^UTILITY(U,$J,358.3,11084,0)
 ;;=N13.6^^68^677^73
 ;;^UTILITY(U,$J,358.3,11084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11084,1,3,0)
 ;;=3^Pyonephrosis
 ;;^UTILITY(U,$J,358.3,11084,1,4,0)
 ;;=4^N13.6
 ;;^UTILITY(U,$J,358.3,11084,2)
 ;;=^101552
 ;;^UTILITY(U,$J,358.3,11085,0)
 ;;=N30.91^^68^677^19
 ;;^UTILITY(U,$J,358.3,11085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11085,1,3,0)
 ;;=3^Cystitis w/ Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,11085,1,4,0)
 ;;=4^N30.91
 ;;^UTILITY(U,$J,358.3,11085,2)
 ;;=^5015643
 ;;^UTILITY(U,$J,358.3,11086,0)
 ;;=N30.90^^68^677^20
 ;;^UTILITY(U,$J,358.3,11086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11086,1,3,0)
 ;;=3^Cystitis w/o Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,11086,1,4,0)
 ;;=4^N30.90
 ;;^UTILITY(U,$J,358.3,11086,2)
 ;;=^5015642
 ;;^UTILITY(U,$J,358.3,11087,0)
 ;;=N41.9^^68^677^38
 ;;^UTILITY(U,$J,358.3,11087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11087,1,3,0)
 ;;=3^Inflammatory Disease of Prostate,Unspec
 ;;^UTILITY(U,$J,358.3,11087,1,4,0)
 ;;=4^N41.9
 ;;^UTILITY(U,$J,358.3,11087,2)
 ;;=^5015694
 ;;^UTILITY(U,$J,358.3,11088,0)
 ;;=N70.91^^68^677^75
 ;;^UTILITY(U,$J,358.3,11088,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11088,1,3,0)
 ;;=3^Salpingitis,Unspec
 ;;^UTILITY(U,$J,358.3,11088,1,4,0)
 ;;=4^N70.91
 ;;^UTILITY(U,$J,358.3,11088,2)
 ;;=^5015806
 ;;^UTILITY(U,$J,358.3,11089,0)
 ;;=N70.93^^68^677^74
 ;;^UTILITY(U,$J,358.3,11089,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11089,1,3,0)
 ;;=3^Salpingitis & Oophoritis,Unspec
 ;;^UTILITY(U,$J,358.3,11089,1,4,0)
 ;;=4^N70.93
 ;;^UTILITY(U,$J,358.3,11089,2)
 ;;=^5015808
 ;;^UTILITY(U,$J,358.3,11090,0)
 ;;=N70.92^^68^677^55
 ;;^UTILITY(U,$J,358.3,11090,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11090,1,3,0)
 ;;=3^Oophoritis,Unspec
 ;;^UTILITY(U,$J,358.3,11090,1,4,0)
 ;;=4^N70.92
 ;;^UTILITY(U,$J,358.3,11090,2)
 ;;=^5015807
 ;;^UTILITY(U,$J,358.3,11091,0)
 ;;=N73.9^^68^677^37
 ;;^UTILITY(U,$J,358.3,11091,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11091,1,3,0)
 ;;=3^Inflammatory Disease Female Pelvic,Unspec
 ;;^UTILITY(U,$J,358.3,11091,1,4,0)
 ;;=4^N73.9
 ;;^UTILITY(U,$J,358.3,11091,2)
 ;;=^5015820
 ;;^UTILITY(U,$J,358.3,11092,0)
 ;;=A56.11^^68^677^36
 ;;^UTILITY(U,$J,358.3,11092,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11092,1,3,0)
 ;;=3^Inflammatory Disease Chlamydial Female Pelvic
 ;;^UTILITY(U,$J,358.3,11092,1,4,0)
 ;;=4^A56.11
 ;;^UTILITY(U,$J,358.3,11092,2)
 ;;=^5000342
 ;;^UTILITY(U,$J,358.3,11093,0)
 ;;=N73.5^^68^677^64
 ;;^UTILITY(U,$J,358.3,11093,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11093,1,3,0)
 ;;=3^Peritonitis Female Pelvic,Unspec
 ;;^UTILITY(U,$J,358.3,11093,1,4,0)
 ;;=4^N73.5
 ;;^UTILITY(U,$J,358.3,11093,2)
 ;;=^5015817
 ;;^UTILITY(U,$J,358.3,11094,0)
 ;;=N72.^^68^677^35
